drugset / Trial / NCT07297316

Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease

NCT07297316

RandomizedSingle-groupDouble-blindTreatment

Summary

This study compares the immediate therapeutic and mucin-secreting effects 30 minutes after instillation of 3% diquafosol and 2% rebamipide in dry eye disease.

Timeline

Start
2022-10-03
Primary completion
2024-08-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diquafosol Oligonucleotide (other) 3 % Topical
Subject Rebamipide Small molecule 2 % Topical

Indications